Our History

 

logo
Invicro is Founded

2008

Invicro was founded with the mission of improving the role of imaging in drug discovery and development across all therapeutic areas.

splash-vq-full-1-390x245-2
Launches Flagship Software Products

2009

Invicro releases its new data management (iPACS®) and image analysis platforms (VivoQuantTM).

3D data processing
Launches Automated 3D Data Processing Throughput

2011

First 3D segmentation method launched in VivoQuantTM.

Boston-3
New Headquarters Established

2013

Invicro opens new headquarters and imaging facilities in Boston, MA and London, UK.

brains-2-1-1
Opens Translational Imaging Center

2014

Invicro opens new translational imaging center at MPI Research in Michigan.

CFT
3D Tissue Imaging Service Released

2015

Invicro offers cryofluorescence tomography (CFT) as a novel 3D tissue imaging service to visualize fluorescently labeled test articles with enhanced resolution and sensitivity. Learn More

Capture
Launches Radiopharmaceutical Supply Chain Services 

2016

Invicro launches services to partner with pharmaceutical & commercial radiopharmaceutical producers to supply radiotracer doses for Phase I-III trials.

mni-2
Molecular NeuroImaging, LLC Acquired

2016

MNI is acquired; strengthening our full spectrum translational imaging expertise. 

imanova
Imanova Acquired

2017

Imanova is acquired; opening London clinic and offices to expand our global imaging analytics and clinical services.

core clinical
Core Clinical Acquired

2017

Invicro expands its clinical operations and opens a satellite office in Pennsylvania.
Learn More About Our Clinical Services

konica minolta
Invicro Joins Konica Minolta

2017

Invicro is acquired by Konica Minolta (KM), to support the expansion of KM's precision medicine vision through molecular digital imaging technologies, advanced analytics and software solutions.

BCa_4B5+UNI_man_40-2x
Launches First Generation of Quanticell™

2018

Developed by Konica Minolta, QuanitcellTM is a novel, highly sensitive and quantitative immunohistochemistry assay that detects biomarkers in context across a broader dynamic range using phosphor-integrated dots.
Learn More  

konica minolta
Konica Minolta Precision Medicine Launches in Japan (KMPMJ)

2018

KMPMJ brings together cutting-edge technologies in genomics, AI-analytics and integrated diagnostics to diagnose, treat and develop new therapies. 

biocare medical
Biocare Medical Pharma Services Acquired

2019

Invicro acquires Biocare Medical Pharma Services to provide partners access to best-in-class clinical anatomical pathology services, including IHC, IF, ISH, pathology interpretation and image analysis in a CAP-accredited, CLIA-certified laboratory.

 

 

tauiq
Launches TauIQ platform in its Core Lab

2021

Invicro launches it's 21 CFR Part 11 compliant TauIQ services in its Core Lab as part of its expanded IQ-Analytics Platform, which includes AmyloidIQ and DaTIQ
Learn More  

aws
Konica Minolta Precision Medicine Collaborates with Amazon Web Services (AWS)

2021

AWS supports the build-out of the company’s LATTICE, a groundbreaking integrated diagnostic data platform that combines genomics, pathology, and radiology data to uncover new, clinically relevant biomarkers and create the next generation of diagnostic tests.